Syrup - 4 mg/5 ml - 100 ml

Tablets - 8 mg

Film coated tablets - 120 mg

Film coated tablets - 120 mg

Film coated tablets - 180 mg

Film coated tablets - 180 mg

Syrup - 15 mg / 5 ml

Tablets - 10 mg

Lorade contains the active substance loratadine, which is part of a group of medicines called antihistamines.

Lorade is used to treat symptoms of allergic rhinitis (e.g. hay fever) and for chronic idiopathic urticaria (hives of unknown origin).

Sugar coated tablets - 50 mg

Mebhydrolin is a substance that is part of the group of antihistamines. The antihistamines reduce or inhibit the main actions of histamine in the organism through the reversible and competitive block of the histamine receptors; they do not disactivate histamine or do not prevent its synthesis or release. Mebhidroline presents antimuscarinic, serotonine antagonist properties and local anaesthetic effects. It is used for the symptomatic relief of hypersensitivity reactions, including urticaria and angioedema, rhinitis and conjunctivitis. It is considered as ineffective in asthma.

Mebhidroline sugar-coated tablet 50 mg is indicated in:

• hay fever;
• vasomotor rhinitis;
• bronchial asthma with an allergic origin;
• urticaria;
• exanthema by drugs;
• itching;
• eczema;
• allergic dermatitis and conjunctivitis;
• insect bites;
• Quincke oedema,
• food idiosyncrasias.

Syrup - 250 mg / 5 ml

Syrup - 100 mg / 5 ml

Solution for injection - 50 mg / 2 ml

Promethazine is a phenothiazine derivative, which decreases or eliminates the main histamine actions by competing with histamine or reversibly blocking histamine receptors in tissues. Promethazine does not deactivate histamine, and does not prevent its secretion. H₁ receptors are responsible for blood vessel dilation, increase of capillary permeability, itching and, up to an extent, for bronchial and gastrointestinal tract smooth muscle contractions. Promethazine has also antimuscarinic properties, antagonizing effects of adrenaline and serotonin and local anesthetic effects.

Prometazine 50 mg / 2 ml solution for injection is indicated:

By intramuscular injection:

• in allergy;
• in preoperative sedation;
• in sedation during labor;

By intravenous injection:

• in allergy

as an adjuvant agent in anaesthesia and analgesia in order to reduce the dose of pethidine or other narcotic analgesics, especially in several specific surgical procedures (for example: repeated bronchoscopy, surgical ophthalmologic intervention).

Syrup - (0.6 mg + 0.08 mg + 40 mg + 90 mg ) / 1 g

Syrup - (0.6 mg + 0.08 mg + 40 mg + 90 mg ) / 1 g

Nasal spray solution - 0.5 mg / ml

Nasal spray solution - 0.25 mg / ml

Nasal drops, solution - 0.9 %

Chewable tablets - 5 mg

Film coated tablets - 10 mg